SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath Inc. is trending as investors aggressively debate whether the stock represents a deep-value opportunity or a value trap while monitoring its pivotal transition into agentic AI orchestration. The community is focused on the high short interest, the company's strong cash position without debt, and the potential for a significant squeeze heading into upcoming earnings.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is facing significant selling pressure amid a broader market rotation and macro concerns, with the community actively debating whether this is a healthy profit-taking dip or the start of a deeper cyclical correction. Investors are closely monitoring upcoming earnings catalysts and potential labor disputes in the semiconductor sector to determine if the stock's long-term AI-driven thesis remains intact.

NIO, Inc. operates as a holding company, which engages in the design, development, manufacture, and sale of smart electric vehicles. It offers its products under the brands NIO, ONVO, and FIREFLY. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Shanghai, China.

NIO Inc - ADR

NIO Inc

NIO is currently experiencing high volatility and intense community debate as investors weigh the company's recent delivery stability and price target upgrades against persistent concerns regarding market manipulation and the sustainability of its business model. The community is actively tracking upcoming earnings results and ongoing U.S.-China trade discussions, which are viewed as key catalysts for potential price movement.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is seeing significant momentum and retail interest, driven by a recent analyst upgrade and news regarding institutional stock purchases, including a disclosed position by Donald Trump. Investors are actively debating whether this movement signals a broader 'SaaS supercycle' and a rebound for software stocks that were previously beaten down, with many discussing the platform's 'embedded stickiness' as a key competitive advantage in the AI era.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is currently trending due to positive momentum from its recent AUA presentation, new patent approvals, and an exclusive deal for the Tokyo BCG strain, which the community views as a strategic solution to the ongoing domestic BCG shortage. Investors are closely monitoring today's FDA workshop on bladder cancer treatments, with active community debate focusing on the company's pending sBLA, potential label expansion, and ongoing efforts to overcome regulatory hurdles.

Trio-Tech International engages in the provision of third-party semiconductor testing and burn-in services. It operates through the following segments: Semiconductor Back-End Solutions (SBS) and Industrial Electronics. The SBS segment is focused on the sale of burn-in and reliability test equipment used in the back-end manufacturing processes of semiconductors. Its equipment includes burn-in systems, burn-in boards, and related equipment that is used in the testing of structural integrity of integrated circuits. The Industrial Electronics segment consists of designing, manufacturing, and distributing a range of tests, processes, and other equipment used in the manufacturing processes of customers in various industries in the consumer and industrial market. The company was founded in 1958 and is headquartered in Los Angeles, CA.

Trio-Tech International

Trio-Tech International is experiencing significant trading activity as investors speculate on its role in the semiconductor reliability and burn-in testing market, particularly for high-performance AI and EV chips. The community is actively debating the company's valuation relative to larger industry peers, with many focusing on its recent revenue growth, expansion plans in Southeast Asia, and the potential impact of its niche capacity on next-generation GPU demand.

Agilysys, Inc. operates as a technology company. It offers innovative software for point-of-sale, payment gateway, reservation and table management, guest offers management, property management, inventory and procurement, analytics, document management, and mobile and wireless solutions and services to the hospitality industry. The firm also serves the gaming industry for both corporate and tribal, hotels resort and cruise, foodservice management, and the restaurant, university, and healthcare sectors. The company was founded in 1963 and is headquartered in Alpharetta, GA.

Agilysys, Inc

Agilysys is trending following a significant beat on both top and bottom lines, alongside a robust fiscal guidance that has fueled investor optimism. The community is actively discussing the stock's growth potential and momentum, with many focused on key technical levels and the company's expanding presence in the hospitality software sector.

Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.

Relay Therapeutics Inc

Relay Therapeutics is trending following the announcement of positive initial clinical data from the Phase 2 ReInspire trial of zovegalisib for vascular anomalies, which demonstrated significant volumetric response and symptomatic improvement. The community is actively discussing the drug's safety profile and potential for chronic use, while traders weigh the impact of these results against the stock's recent volatility and broader biotech sector performance.

Oxford Lane Capital Corp. is a closed-end management investment company, which engages in investing in debt and equity tranches of collateralized loan obligation vehicles. The company was founded on June 9, 2010 and is headquartered in Greenwich, CT.

Oxford Lane Capital Corp

Oxford Lane Capital is experiencing significant selling pressure following a disappointing quarterly earnings report that revealed lower-than-expected revenue and a major dividend reduction. The community is actively debating the company's management decisions and the sustainability of its CLO investment strategy amidst broader concerns about the private credit sector.

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

Hyperliquid Strategies Inc. ($PURR) is trending as traders speculate on the impact of potential SEC innovation exemptions for tokenized stocks and its correlation with the HYPE token's market performance. The community remains divided, with some investors bullish on the company's exposure to decentralized infrastructure and staking revenue, while others remain skeptical of the stock's volatility and its past status as a biotech entity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


IDIX
Idenix Pharmaceuticals Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest IDIX News

IDIXIdenix Pharmaceuticals Inc.